Statin therapy reduces troponin concentration, which predicts future coronary risk independently of cholesterol lowering.
Do serial high-sensitivity cardiac troponin measurements predict future coronary risk and monitor the impact of statin therapy?
Serial high-sensitivity cardiac troponin measurements have major potential to assess cardiovascular risk and monitor the therapeutic impact of statins independent of cholesterol lowering.
Absolute Event Rate: 0% vs 0%
Troponin concentration predicts coronary events, is reduced by statin therapy, and change at 1 year is associated with future coronary risk independent of cholesterol lowering. Serial troponin measurements have major potential to assess cardiovascular risk and monitor the impact of therapeutic interventions.
Ford et al. (Thu,) reported a other. Statin therapy reduces troponin concentration, which predicts future coronary risk independently of cholesterol lowering.